Glenmark Pharmaceuticals Limited is a leading Indian pharmaceutical company that operates in the generic pharma sector. The company has a global presence, with operations in more than 80 countries, including the United States, Europe, Latin America, and Asia. Glenmark is committed to providing affordable and high-quality medicines to patients worldwide.

In recent years, Glenmark has taken several steps to reduce its carbon footprint and promote sustainability. The company has set ambitious targets for decarbonisation and is working towards reducing its greenhouse gas emissions by 30% by 2030. To achieve this, Glenmark has implemented several initiatives, including energy-efficient lighting, HVAC systems, and renewable energy sources.

Corporate energy management is a key focus area for Glenmark. The company has implemented an energy management system that monitors and optimises its energy consumption. This system has helped Glenmark to reduce its energy consumption and costs, while also improving its environmental performance.

Glenmark has also adopted a corporate power purchase agreement (PPA) to procure renewable energy. Through this agreement, the company has committed to purchasing a significant portion of its electricity from renewable sources, such as wind and solar. This has helped Glenmark to reduce its carbon emissions and support the growth of renewable energy in India.

Renewable energy is a key priority for Glenmark. The company has installed solar panels at several of its manufacturing facilities and offices in India, which has helped to reduce its reliance on grid electricity and lower its carbon footprint. Glenmark is also exploring other renewable energy sources, such as wind and biomass, to further reduce its environmental impact.

In addition to its environmental initiatives, Glenmark is committed to promoting sustainability across its operations. The company has implemented several initiatives to reduce waste, conserve water, and promote biodiversity. Glenmark has also established a green procurement policy that encourages the use of environmentally friendly products and services.

Glenmark's commitment to sustainability has been recognised by several industry bodies and organisations. The company has been included in the Dow Jones Sustainability Indices (DJSI) for three consecutive years, which recognises companies that demonstrate leadership in sustainability. Glenmark has also been recognised by the Confederation of Indian Industry (CII) for its sustainability initiatives.

In conclusion, Glenmark Pharmaceuticals Limited is a leading Indian pharmaceutical company that operates in the generic pharma sector. The company is committed to promoting sustainability and reducing its environmental impact. Glenmark has set ambitious targets for decarbonisation and is working towards reducing its greenhouse gas emissions by 30% by 2030. The company has implemented several initiatives to reduce its energy consumption, promote renewable energy, and support sustainability across its operations. Glenmark's commitment to sustainability has been recognised by several industry bodies and organisations, highlighting the company's leadership in this area.